Advertisement

Topics

Pamplona Capital Management Nears Deal to Buy Parexel

05:26 EDT 20 Jun 2017 | Fox Business

Private-equity firm Pamplona Capital Management is nearing a deal to buy Parexel International Corp. for $4.6 billion, according to people familiar with the matter, the latest in a series of mergers among drug-research firms.

Original Article: Pamplona Capital Management Nears Deal to Buy Parexel

NEXT ARTICLE

More From BioPortfolio on "Pamplona Capital Management Nears Deal to Buy Parexel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...